Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

104 studies were found about Specific Populations, Female Only

Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome

Condition: HIV (Human Immunodeficiency Virus); Metabolic Syndrome; HIV Infections

NCT ID: NCT00857298

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Condition: HIV; HIV Infections; Pregnancy

NCT ID: NCT00855335

Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT01433185

Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women

Condition: Hazardous Alcohol Use; Binge Drinking; High Risk Sexual Behaviors; HIV Risk Reduction; HIV Infection

NCT ID: NCT01125371

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01705574

HIV Testing & Womens Attitudes on HIV Vaccine Trials

Condition: HIV Infections

NCT ID: NCT00771537

Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel

Condition: HIV Infections

NCT ID: NCT00197366

Comparison of Two IUDs Among Cape Town HIV-positive Women: A Randomized Controlled Trial Assessing Safety of Registered Products in South Africa

Condition: HIV

NCT ID: NCT01721798

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00150098

Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women

Condition: Cervical Dysplasia in HIV Positive Women

NCT ID: NCT01723956

Trial of SAVVY Vaginal Gel and HIV in Nigeria

Condition: HIV Infections

NCT ID: NCT00130078

Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection

Condition: HIV; Pregnancy

NCT ID: NCT01854762

Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women

Condition: Pregnancy; HIV Infections; Sexually Transmitted Diseases

NCT ID: NCT00628771

Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

Condition: HIV Infections

NCT ID: NCT01539226

Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women

Condition: HIV Infections

NCT ID: NCT01617096

Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers

Condition: HIV Infections

NCT ID: NCT01511237

Clinical Trial to Reduce Drinking in Women With HIV

Condition: HIV Infection

NCT ID: NCT01625091

Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT01157442

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Condition: HIV Infections

NCT ID: NCT00825929

Study to Improve Survival Among HIV-Exposed Infants in Botswana

Condition: HIV Infections; Neutropenia; Anemia

NCT ID: NCT01229761

Dating Violence and HIV Prevention in Girls: Adapting Mental Health Interventions

Condition: Dating Violence; HIV Infections

NCT ID: NCT01326195

Safety of Acidform Lubricant in HIV-Uninfected Women

Condition: HIV Infections

NCT ID: NCT00850837

Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera

Condition: HIV-1 Infection

NCT ID: NCT01701895

Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

Condition: Influenza, Human; HIV; Malaria; Tetanus; Polio

NCT ID: NCT01810731

Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.

Condition: 1- Women; 2- HIV Infection; 3- Followed in West Indies and French Guiana for His Infection; 4- Acceptance of the Use of Nadis® Medical Files

NCT ID: NCT01226368

Women's Interagency HIV Study (WIHS)

Condition: HIV Infections

NCT ID: NCT00000797

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Condition: HIV Prevention

NCT ID: NCT01386294

Evaluation of Barriers to Postpartum Care in HIV Infected Women

Condition: HIV Infection; Pregnancy

NCT ID: NCT01853917

Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials

Condition: HIV Infections

NCT ID: NCT00514098

HIV and Drug Use in Georgian Women

Condition: Human Immunodeficiency Virus

NCT ID: NCT01331460

Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum

Condition: Malaria in Pregnancy; HIV Infection

NCT ID: NCT01746199

Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women

Condition: Pneumococcal Infections; HIV Infections

NCT ID: NCT01443117

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01494038

Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma

Condition: HIV

NCT ID: NCT01625169

Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

Condition: HIV Infections

NCT ID: NCT01618305

A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries

Condition: HIV

NCT ID: NCT00341302

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

Condition: HIV; Hepatitis B

NCT ID: NCT01125696

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

Condition: Cervical Cancer; Acquired Immunodeficiency Syndrome

NCT ID: NCT01590017

HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women

Condition: HIV-1 Infection

NCT ID: NCT01315353

Brief Intervention for Rural Women at High Risk for HIV/HCV

Condition: Acquired Immune Deficiency Syndrome Virus; Hepatitis C; Drug Abuse

NCT ID: NCT01840722

Vitamin D HIV Study

Condition: HIV

NCT ID: NCT01375010

Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women

Condition: Influenza; Human Immunodeficiency Virus

NCT ID: NCT01812980

Vaginal Innate Immunity in Normal and HIV-Infected Women

Condition: HIV; Pregnancy

NCT ID: NCT01318304

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

Condition: HIV Infection; Pregnancy

NCT ID: NCT01621347

Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis

Condition: HIV; Tuberculosis

NCT ID: NCT01635153

A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

Condition: HIV Infections; Contraception; Pharmacokinetics

NCT ID: NCT00482963

Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women

Condition: HIV

NCT ID: NCT01749566

EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine

Condition: HIV

NCT ID: NCT01509144

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

Condition: HIV Infections; Cachexia

NCT ID: NCT00004400

Pilot Study: Acceptability, Feasibility and Efficacy of Vaginal Insemination in HIV Discordant Couples (Female Positive, Male Negative) Desiring Conception in Kisumu, Kenya

Condition: HIV Discordant Couples

NCT ID: NCT01468753

Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine

Condition: - HIV

NCT ID: NCT01827397

Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women

Condition: HIV Infected Women; Healthy Women Volunteers

NCT ID: NCT01715103

Cambodia Integrated HIV and Drug Prevention Implementation Program

Condition: HIV

NCT ID: NCT01835574

Effects of Cash Transfer for the Prevention of HIV in Young South African Women

Condition: HIV

NCT ID: NCT01233531

Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women

Condition: HIV Infections

NCT ID: NCT01490671

The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception

Condition: Pregnancy; HIV; AIDS

NCT ID: NCT01667978

Violence and HIV Risk Among Women

Condition: HIV Risk Reduction

NCT ID: NCT01695694

Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity

Condition: HIV Prevention

NCT ID: NCT01810315

Assessing the Safety of Dapivirine Gel and Film Formulations

Condition: HIV Infections

NCT ID: NCT01548560

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

Condition: Birth Defects; Infection, Human Immunodeficiency Virus

NCT ID: NCT01137981

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

Condition: HIV Infections

NCT ID: NCT00214812

Examining Benefits of HAART Continuation in Postpartum Mothers

Condition: HIV Infections

NCT ID: NCT00955968

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

Condition: HIV Infections; Hepatitis B Virus

NCT ID: NCT00404989

Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir

Condition: HIV

NCT ID: NCT01597180

Education Program to Promote Female Condom Use

Condition: HIV Infections

NCT ID: NCT00062634

Cryotherapy vs. LEEP to Treat CIN2/3 Among HIV-positive Women

Condition: Cervical Intraepithelial Neoplasia

NCT ID: NCT01298596

Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission

Condition: HIV Infections; Pregnancy Complications, Infectious

NCT ID: NCT00028145

Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population

Condition: Hepatitis C Virus; HIV Infections; Pregnancy

NCT ID: NCT00894257

Tenofovir Gel in Pregnancy and Lactation

Condition: HIV Infections

NCT ID: NCT01136759

Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract

Condition: Women's Health; HIV Infection; Genital Diseases, Female

NCT ID: NCT01456962

A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication

Condition: HIV Infection

NCT ID: NCT01865786

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289

A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women

Condition: Cancer Prevention; Cervix

NCT ID: NCT01605656

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy

Condition: HIV; Contraception

NCT ID: NCT01789879

DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate

Condition: HIV

NCT ID: NCT01731574

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Condition: Human Papillomavirus Infection

NCT ID: NCT01031069

WHC+ (Women's Health CoOp PLUS)

Condition: HIV; Sexual Risk; Sexually Transmitted Diseases; Substance Abuse; Violence; Victimization

NCT ID: NCT01497405

Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services

Condition: HIV

NCT ID: NCT01838005

SCOPE: Strategies to Combine PrEP With Prevention Efforts

Condition: HIV

NCT ID: NCT01832571

Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services

Condition: HIV

NCT ID: NCT01691768

Monoclonal Antibody-based Multipurpose Microbicides

Condition: HIV; Sexually Transmitted Infections (STI)

NCT ID: NCT01859195

Implementation of an Efficacious Intervention for High Risk Women in Mexico

Condition: HIV; Syphilis; Gonorrhea; Chlamydia

NCT ID: NCT01465607

Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine

Condition: HIV

NCT ID: NCT01694407

Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution

Condition: HIV

NCT ID: NCT00260767

Quantification of Immune Cells in Women Using Contraception (CHIC II)

Condition: HIV; Immune Cells (Mucosal and Systemic); Contraception

NCT ID: NCT01873170

Levels of Raltegravir in the Female Genital Tissue

Condition: HIV

NCT ID: NCT01327482

HIV Prevention Intervention for Young Transgender Women

Condition: Sexual Transmission of Infection

NCT ID: NCT01575938

Project N-Liten- HIV Prevention for African American Women

Condition: Sexually Transmitted Diseases

NCT ID: NCT01553682

HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study

Condition: Cervical Cancer

NCT ID: NCT01792973

Cognitive Processing Intervention for Trauma, HIV/STI Risks, and Substance Use Among Native Women

Condition: Post Traumatic Stress Disorders; Unsafe Sex; Substance Use Disorders

NCT ID: NCT01849029

Biomarkers of Protocol Compliance and Product Adherence

Condition: HIV Prevention

NCT ID: NCT01804023

Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel

Condition: HIV Prevention

NCT ID: NCT01768962

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products

Condition: HIV Prevention

NCT ID: NCT01813162

Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use

Condition: HIV Prevention

NCT ID: NCT01421368

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

Condition: NVP Plasma Level; NVP Related Mutation; 3TC Related Mutation

NCT ID: NCT00872872

Trichomonas Vaginalis Repeat Infections Among HIV Negative Women

Condition: Vaginitis Trichomonal or Due to Trichomonas; Partner Communication

NCT ID: NCT01832480

DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women

Condition: Trichomonas Vaginalis

NCT ID: NCT01874158

Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women

Condition: Influenza

NCT ID: NCT01816464

Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women

Condition: Influenza

NCT ID: NCT01527825

Preparedness Study - HPV Vaccine

Condition: Sexual Transmission of Infection

NCT ID: NCT01489527

Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn

Condition: Infant, Newborn, Diseases; Sepsis; Puerperal Infection

NCT ID: NCT00136370

Improving Effective Contraceptive Use Among Opioid-maintained Women

Condition: Contraceptive Usage; Opioid Dependence

NCT ID: NCT01425060

Long-Acting Reversible Contraception

Condition: Contraception

NCT ID: NCT01299116

Safety,Effectiveness and Acceptability of Sino-implant II

Condition: Contraception

NCT ID: NCT01594632